Financial research concept

Medtech Hips Constant-Currency Sales Growth

measures hip implant and related product revenue growth after removing foreign-currency translation effects.

By Lee BaileyPublished Oct 1, 2026

Research context

See what supports this page, how current it is, and where comparable or historical context is available.

Research date: Oct 1, 2026Use the dated article and cited sources for the definition, examples, and stated limitations.
Operating-model context: 10 connected conceptsPart of the reviewed Medtech Product Family Economics; issuer definitions remain distinct where disclosed.
Company examples: 1 reviewed companyRelationships reflect supported examples, not a normalized cross-company KPI ranking.

U.S. growth offset international softness
Product sales are not a procedure count
Part of the Medtech Product Family Economics
See It in Company Research
Continue Research

Medtech hips constant-currency sales growth measures hip product revenue growth after removing foreign-currency translation effects.

Stryker reported 2.6% constant-currency growth in Hips for the second quarter of 2026. Revenue was $479M, compared with $466M a year earlier.

U.S. growth offset international softness

U.S. Hips revenue increased 4.9%, while international revenue declined 0.8% on a constant-currency basis.

The total growth rate therefore reflects materially different regional demand.

Product sales are not a procedure count

Hip revenue can move with procedure volume, implant mix, pricing, geography, and technology adoption.

Read it with Knees constant-currency sales growth and Orthopaedics operating margin.

Primary source: Stryker Q2 2026 Form 10-Q.

Part of the Medtech Product Family Economics

Connects Stryker product-family constant-currency demand with reportable-segment operating-margin conversion.

Browse the full operating model in Company Analysis →

Where this concept fits

Orthopaedics product growthCurrent relationship
Knees, Hips, Trauma and Extremities, and Ortho Tech constant-currency growth separate major orthopaedic demand pools while preserving Stryker's 2026 organizational recast.
Hips Constant-Currency GrowthCurrent conceptKnees Constant-Currency Growth Ortho Tech Constant-Currency Growth Trauma & Extremities Constant-Currency Growth
MedSurg and Neurotechnology product growth
Instruments, Endoscopy, Medical, and Vascular constant-currency growth show how demand differs across Stryker's MedSurg and Neurotechnology product families.
Endoscopy Constant-Currency Growth Instruments Constant-Currency Growth Medical Constant-Currency Growth Vascular Constant-Currency Growth
Segment operating conversion
Operating margin shows how MedSurg and Neurotechnology and Orthopaedics convert product-family demand through volume, manufacturing and supply-chain costs, R&D, and SG&A.
MedSurg & Neurotechnology Margin Orthopaedics Operating Margin

See It in Company Research

These companies are examples of how the concept is reported or discussed in public filings. Definitions can differ by issuer; these links open company research rather than a normalized metric comparison.

SYKOpen operating-model research →10 of 10 reviewed concepts in Medtech Product Family EconomicsOrthopaedics product growth4 of 4 bridge concepts supportedContinue through this bridge:Knees Constant-Currency Growth Ortho Tech Constant-Currency Growth Trauma & Extremities Constant-Currency Growth

Continue Research

Continue from the concept into the Grizzly Bulls research surface that best matches the next question. These links are research continuations, not recommendations or required steps.

Compare stocks

Compare hip product growth

Compare hip revenue growth while preserving geography, implant mix, pricing, and procedure-volume boundaries.

Continue research

Explore more topics in the Financial Research Encyclopedia.